220 related articles for article (PubMed ID: 25348176)
1. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
3. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
4. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
Augustsson C; Hilden I; Petersen LC
Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
7. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
8. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
Mast AE; Ruf W
J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
[TBL] [Abstract][Full Text] [Related]
10. A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X.
Al Dieri R; Bloemen S; Kelchtermans H; Wagenvoord R; Hemker HC
J Thromb Haemost; 2013 Mar; 11(3):503-11. PubMed ID: 23294934
[TBL] [Abstract][Full Text] [Related]
11. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
Ndonwi M; Broze G; Bajaj SP
J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
[TBL] [Abstract][Full Text] [Related]
12. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
13. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
14. Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.
Fernandes N; Mosnier LO; Tonnu L; Heeb MJ
J Thromb Haemost; 2010 Sep; 8(9):1976-85. PubMed ID: 20492471
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
[TBL] [Abstract][Full Text] [Related]
16. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
17. TFPI-dependent activities of protein S.
Peraramelli S; Rosing J; Hackeng TM
Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
[TBL] [Abstract][Full Text] [Related]
18. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
[TBL] [Abstract][Full Text] [Related]
19. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
[TBL] [Abstract][Full Text] [Related]
20. A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.
Dahlbäck B; Tran S
J Thromb Haemost; 2022 May; 20(5):1146-1157. PubMed ID: 35247027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
